OPK
Opko Health Inc
1.60$
+0.6%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 73.3% | 75.4% | 75.8% | 71.6% | 76.9% | 53.9% | 84.8% | 80.9% | 80.0% | 69.7% | 78.4% | 51.1% | 69.0% | |
| 26.7% | 24.6% | 24.2% | 28.4% | 23.1% | 46.1% | 15.2% | 19.1% | 20.0% | 30.3% | 21.6% | 48.9% | 31.0% | |
| 10.9% | 10.7% | 12.6% | 13.2% | 16.6% | 16.6% | 20.6% | 19.3% | 19.8% | 22.1% | 23.5% | 20.3% | 21.3% | |
| 40.5% | 40.1% | 40.4% | 37.8% | 56.6% | 36.5% | 39.4% | 38.0% | 35.5% | 34.0% | 39.1% | 32.4% | 35.0% | |
| 62.8% | 62.5% | 65.4% | 62.2% | 14.9% | 64.1% | 60.0% | 57.4% | 55.3% | 56.1% | 62.6% | 53.2% | 56.5% | |
| -36.1% | -38.0% | -41.2% | -33.9% | 8.2% | -18.0% | -44.8% | -38.3% | -35.3% | -25.8% | -41.1% | -4.3% | -25.5% | |
| 1.9% | 1.9% | 4.4% | 4.5% | 10.0% | 7.8% | 10.3% | 44.8% | 7.5% | 7.6% | 8.8% | 7.0% | 7.7% | |
| -43.9% | -39.9% | -47.9% | -5.8% | 27.9% | 19.1% | -48.9% | -103.6% | 27.3% | -31.6% | -49.1% | -8.2% | -13.6% | |
| 3.4% | -3.3% | -0.8% | -0.2% | 13.5% | 11.4% | -3.8% | -9.0% | 13.1% | -10.5% | -4.9% | -3.0% | -1.2% | |
| -47.3% | -36.5% | -47.1% | -5.7% | 14.3% | 7.6% | -45.1% | -94.7% | 14.3% | -21.1% | -44.2% | -5.1% | -12.4% | |
| -27.3% | -23.7% | -28.6% | 11.9% | 51.8% | 39.8% | -23.0% | -44.1% | 49.8% | -8.9% | -22.4% | 7.3% | 7.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.